Reports for PENDOPHARM DIVISION OF PHARMASCIENCE INC
Company Name
PENDOPHARM DIVISION OF PHARMASCIENCE INC
Totals |
||
Shortage reports |
130 |
|
| Actual shortage: | 3 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (4%) | |
| Resolved: | 122 (94%) | |
Discontinuation Reports |
3 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (67%) | |
| Reversed: | 1 (33%) | |
Late reports |
17 (13%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| XYLAC | 2.5MG | TABLET | Resolved | 2017-08-15 | 2017-10-05 | 19370 |
| XYLAC | 2.5MG | TABLET | Resolved | 2024-02-22 | 2024-05-10 | 220293 |
| XYLAC | 2.5MG | TABLET | Resolved | 2024-07-11 | 2024-09-23 | 232696 |
| PDP-BENZTROPINE | 1MG | TABLET | Avoided shortage | 2017-09-01 | 2017-10-30 | 20812 |
| PDP-BENZTROPINE | 1MG | TABLET | Resolved | 2018-01-08 | 2018-02-19 | 35082 |
| IBAVYR | 400MG | TABLET | Resolved | 2022-11-14 | 2025-07-30 | 174659 |
| IBAVYR | 200MG | TABLET | Resolved | 2019-12-19 | 2020-03-11 | 101774 |
| IBAVYR | 200MG | TABLET | Resolved | 2020-03-16 | 2020-04-03 | 108738 |
| IBAVYR | 200MG | TABLET | Resolved | 2022-11-14 | 2025-07-30 | 174655 |
| MYINFLA | 0.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-10-11 | 2025-05-08 | 239848 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OCPHYL | 500MCG | SOLUTION | Reversed | 2017-04-10 | 2017-04-10 | 6237 |
| IBAVYR | 400MG | TABLET | Discontinued | 2023-01-20 | 2023-01-20 | 182029 |
| IBAVYR | 200MG | TABLET | Discontinued | 2023-01-20 | 2023-01-20 | 182060 |
Showing 1 to 3 of 3